09.09.2026
Diagnostics
$7,379,942.00
45 months
STAR 3.0: Unraveling the symptoms of stricturing Crohn's disease - A critical step to accelerate the development of effective anti-stricture therapies
Optimize and validate the stricturing Crohn's disease (CD) patient-reported outcome instrument (S-PRO) to support its regulatory acceptance as a key endpoint for anti-stricturing therapeutic clinical trials.